Sean G Yates, MD | |
5201 Harry Hines Blvd, Graduate Medical Education, Dallas, TX 75235-7708 | |
(214) 590-8058 | |
Not Available |
Full Name | Sean G Yates |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 13 Years |
Location | 5201 Harry Hines Blvd, Dallas, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770873200 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZB0001X | Pathology - Blood Banking & Transfusion Medicine | Q5741 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ut Southwestern University Hospital - William P. Clements Jr. | Dallas, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
Spotting a single cancerous cell that has broken free from a tumor and is traveling through the bloodstream to colonize a new organ might seem like finding a needle in a haystack. But a new imaging technique from the University of Washington is a first step toward making this possible.UW researchers have developed a multifunctional nanoparticle that eliminates the background noise, enabling a more precise form of medical imaging - essentially erasing the haystack, so the needle shines through. A successful demonstration with photoacoustic imaging was reported today (July 27) in the journal Nature Communications.
In follow-up to the I HART CGM study, which showed the benefit of real-time continuous glucose monitoring compared to flash monitoring for time spent in hypoglycemia among adults with type 1 diabetes at high hypoglycemia risk, researchers conducted an extension trial that assessed the effects of continuing RT-CGM or switching from flash to RT-CGM of the subsequent 8 weeks.
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade glioma (HGG).
Mechanical loading, or forces that stimulate cellular growth for development, is required for creating cartilage that is then turned to bone; however, little is known about cartilage development in the absence of gravity or mechanical loads.
Clinical investigators from Hackensack Meridian Health John Theurer Cancer Center (JTCC), a member of the Georgetown Lombardi Comprehensive Cancer Center consortium, are to present updates on treatment advances in multiple myeloma (MM), mantle cell lymphoma (MCL), and other types of B-cell lymphoma (BCL) as well as leukemia at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, to be held virtually from December 5-8, 2020.
› Verified 7 days ago
Entity Name | University Of Texas Southwestern Medical Center At Dallas |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Spotting a single cancerous cell that has broken free from a tumor and is traveling through the bloodstream to colonize a new organ might seem like finding a needle in a haystack. But a new imaging technique from the University of Washington is a first step toward making this possible.UW researchers have developed a multifunctional nanoparticle that eliminates the background noise, enabling a more precise form of medical imaging - essentially erasing the haystack, so the needle shines through. A successful demonstration with photoacoustic imaging was reported today (July 27) in the journal Nature Communications.
In follow-up to the I HART CGM study, which showed the benefit of real-time continuous glucose monitoring compared to flash monitoring for time spent in hypoglycemia among adults with type 1 diabetes at high hypoglycemia risk, researchers conducted an extension trial that assessed the effects of continuing RT-CGM or switching from flash to RT-CGM of the subsequent 8 weeks.
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade glioma (HGG).
Mechanical loading, or forces that stimulate cellular growth for development, is required for creating cartilage that is then turned to bone; however, little is known about cartilage development in the absence of gravity or mechanical loads.
Clinical investigators from Hackensack Meridian Health John Theurer Cancer Center (JTCC), a member of the Georgetown Lombardi Comprehensive Cancer Center consortium, are to present updates on treatment advances in multiple myeloma (MM), mantle cell lymphoma (MCL), and other types of B-cell lymphoma (BCL) as well as leukemia at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, to be held virtually from December 5-8, 2020.
› Verified 7 days ago
Entity Name | Utmb Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
Spotting a single cancerous cell that has broken free from a tumor and is traveling through the bloodstream to colonize a new organ might seem like finding a needle in a haystack. But a new imaging technique from the University of Washington is a first step toward making this possible.UW researchers have developed a multifunctional nanoparticle that eliminates the background noise, enabling a more precise form of medical imaging - essentially erasing the haystack, so the needle shines through. A successful demonstration with photoacoustic imaging was reported today (July 27) in the journal Nature Communications.
In follow-up to the I HART CGM study, which showed the benefit of real-time continuous glucose monitoring compared to flash monitoring for time spent in hypoglycemia among adults with type 1 diabetes at high hypoglycemia risk, researchers conducted an extension trial that assessed the effects of continuing RT-CGM or switching from flash to RT-CGM of the subsequent 8 weeks.
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade glioma (HGG).
Mechanical loading, or forces that stimulate cellular growth for development, is required for creating cartilage that is then turned to bone; however, little is known about cartilage development in the absence of gravity or mechanical loads.
Clinical investigators from Hackensack Meridian Health John Theurer Cancer Center (JTCC), a member of the Georgetown Lombardi Comprehensive Cancer Center consortium, are to present updates on treatment advances in multiple myeloma (MM), mantle cell lymphoma (MCL), and other types of B-cell lymphoma (BCL) as well as leukemia at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, to be held virtually from December 5-8, 2020.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Sean G Yates, MD Po Box 660599, Dallas, TX 75266-0599 Ph: () - | Sean G Yates, MD 5201 Harry Hines Blvd, Graduate Medical Education, Dallas, TX 75235-7708 Ph: (214) 590-8058 |
News Archive
Spotting a single cancerous cell that has broken free from a tumor and is traveling through the bloodstream to colonize a new organ might seem like finding a needle in a haystack. But a new imaging technique from the University of Washington is a first step toward making this possible.UW researchers have developed a multifunctional nanoparticle that eliminates the background noise, enabling a more precise form of medical imaging - essentially erasing the haystack, so the needle shines through. A successful demonstration with photoacoustic imaging was reported today (July 27) in the journal Nature Communications.
In follow-up to the I HART CGM study, which showed the benefit of real-time continuous glucose monitoring compared to flash monitoring for time spent in hypoglycemia among adults with type 1 diabetes at high hypoglycemia risk, researchers conducted an extension trial that assessed the effects of continuing RT-CGM or switching from flash to RT-CGM of the subsequent 8 weeks.
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade glioma (HGG).
Mechanical loading, or forces that stimulate cellular growth for development, is required for creating cartilage that is then turned to bone; however, little is known about cartilage development in the absence of gravity or mechanical loads.
Clinical investigators from Hackensack Meridian Health John Theurer Cancer Center (JTCC), a member of the Georgetown Lombardi Comprehensive Cancer Center consortium, are to present updates on treatment advances in multiple myeloma (MM), mantle cell lymphoma (MCL), and other types of B-cell lymphoma (BCL) as well as leukemia at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, to be held virtually from December 5-8, 2020.
› Verified 7 days ago
Dr. Jaime Albert Campbell, M.D., M.S. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave, Baylor University Medical Center, Dept Of Pathology, Dallas, TX 75246 Phone: 214-820-3772 | |
Brianne Flynn, Pathology Medicare: Not Enrolled in Medicare Practice Location: 2355 N Stemmons Fwy, Dallas, TX 75207 Phone: 214-920-5900 | |
Dr. Timothy Joseph Kirtek, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd Stop 7200, Dallas, TX 75390 Phone: 214-648-3433 | |
Keith Allen Wharton Jr., MD PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-1620 Fax: 214-648-4080 | |
Dinesh Rakheja, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-1620 Fax: 214-648-4080 | |
Dr. Emmy L. Kiss, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-590-6494 | |
Thomas Hugh Mcconnell, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3401 Lee Pkwy Apt 304, Dallas, TX 75219 Phone: 214-363-2221 Fax: 214-363-2228 |